Jose R Romero
Affiliation: University of Nebraska Medical Center
- Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usageJose R Romero
Combined Section of Infectious Disease, Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE 68178, USA
Pediatr Infect Dis J 22:S46-54. 2003..Analysis of 2830 medical records revealed an admission rate of 2.4% (68 of 2830) for confirmed RSV infection, consistent with the overall hospitalization rate of 2.3% from the previous season...
- The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine modelJames J Dunn
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
J Infect Dis 187:1552-61. 2003..The identity of this higher-order RNA structure may be essential for productive infection of cardiac cells...
- Viral meningitis and encephalitis: traditional and emerging viral agentsJose R Romero
Combined Division of Pediatric Infectious Diseases, Associate Professor of Pediatrics, Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68178, USA
Semin Pediatr Infect Dis 14:72-82. 2003..and emerging (West Nile virus) viral pathogens...
- Molecular diagnosis of viral infections of the central nervous systemJose R Romero
Combined Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Nebraska Medical Center and Creighton University, 982165 Nebraska Medical Center, Omaha, NE 68198, USA
Clin Lab Med 23:843-65, vi. 2003..This article summarizes the current understanding with regard to the available, molecularly based, diagnostic assays for the detection of EVs, herpes viruses, and JCV...
- Powassan encephalitis and Colorado tick feverJose R Romero
Section of Pediatric Infectious Diseases, Department of Pediatrics, University of Nebraska Medical Center, 982162 Nebraska Medical Center, Omaha, NE 68198 2162, USA
Infect Dis Clin North Am 22:545-59, x. 2008....
- Pediatric group B coxsackievirus infectionsJ R Romero
University of Nebraska Medical Center, 986495 Nebraska Medical, Omaha, NE 68198 6495, USA
Curr Top Microbiol Immunol 323:223-39. 2008..This review will focus on the more common or clinically relevant CVB-related syndromes, their diagnosis, treatment, and prevention...
- Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infantsJose R Romero
Department of Pediatrics, Arkansas Children s Hospital and University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202 3591, USA
Clin Ther 32:2422-32. 2010..Respiratory syncytial virus (RSV) lower respiratory tract infection (LRI) in early life has been associated with sustained airway hyperreactivity during childhood; however, corresponding data in premature infants are sparse...
- Diagnosis of viral encephalitides: zoonotic-associated virusesJose R Romero
University of Nebraska Medical Center, Omaha, NE, USA
Pediatr Infect Dis J 25:741-2. 2006
- West Nile VirusEdward J Truemper
Pediatric Intensive Care Unit, University of Nebraska Medical Center, Omaha, NE 68198 2162, USA
Pediatr Ann 36:414-22. 2007
- Encephalitis associated with influenza B virus infection in 2 children and a review of the literatureJason G Newland
Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE 68171, USA
Clin Infect Dis 36:e87-95. 2003..These cases reveal the spectrum of IBAE and its potential for long-term sequelae. Clinicians caring for children should remain vigilant for this rare complication of influenza B virus infection...
- Safety of oseltamivir compared with the adamantanes in children less than 12 months of ageDavid W Kimberlin
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama, Birmingham, Birmingham, AL 35233, USA
Pediatr Infect Dis J 29:195-8. 2010..To assess potential neurologic adverse effects of oseltamivir use in infants, a retrospective chart review was performed in infants less than 12 months of age who received oseltamivir, amantadine, or rimantadine...